<DOC>
	<DOCNO>NCT00803829</DOCNO>
	<brief_summary>Ulcerative colitis ( UC ) one two main form inflammatory bowel disease . UC associate high morbidity incurs significant social , commercial NHS cost . For variety reason , many patient refractile standard therapy , often undesirable side-effects . However , inexpensive non-toxic treatment base synbiotic concept may prove effective individual . A synbiotic mixture probiotic ( live microorganism ) prebiotic , carbohydrate serf food source probiotic , allow grow well gut . The aim study determine whether synbiotic comprise fructooligosaccharides inulin , together bifidobacterial probiotic ( Bifidobacterium longum ) , previously show reduce inflammatory process gut wall ( mucosa ) short-term pilot trial , colonise bowel , reduce mucosal inflammation , induce remission UC patient active disease . It plan establish double-blinded , control , randomise investigation involve 46 patient six month . If result pilot study reproduce maintain long-term investigation , synbiotic could become available quickly , would provide inexpensive effective treatment UC , make significant contribution relieve clinical financial burden disease .</brief_summary>
	<brief_title>Synbiotic Treatment Ulcerative Colitis Patients</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Ulcerative colitis Stable dos medication UC precede three month Mayo score 6 12 Sigmoidoscopy subscore 2 Stable dos medication Pregnancy Lactation Antibiotic therapy last three month Probiotic prebiotic therapy last month Crohn 's Disease , indeterminate colitis Alterations medication last three month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>